SCHEMBL19145598

SCHEMBL19145598

COC(=O)Cn1ccc2cc(-n3cc(-c4cc5cc(F)ccc5[nH]c4=O)nn3)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.38
▸ MIF P14174 3/20 0.36
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ KDR P35968 5/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CA12 O43570 2/20 0.34
▸ CA1 P00915 2/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ PTPN7 P35236 1/20 0.34
▸ BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19145204 0.90 MIF (0.45) MIFCDK5CDK5R1KDRALDH1A1
SCHEMBL19126839 0.85 KDR (0.47) KDRCXCR3FLT3VCP
SCHEMBL19127238 0.80 DHODH (0.47) CDK5CDK5R1KDRALDH1A1KDM4E
SCHEMBL19126535 0.80 ALDH1A1 (0.47) MIFCDK5CDK5R1ALDH1A1KDM4E
SCHEMBL19145552 0.76 KDR (0.48) CDK5CDK5R1KDRALDH1A1KDM4E
SCHEMBL19145729 0.76 DAO (0.47) MIFCDK5CDK5R1KDRALDH1A1
SCHEMBL22110441 0.76 CDK5 (0.45) CDK5CDK5R1KDRALDH1A1KDM4E
SCHEMBL19126504 0.76 CDK5 (0.43) MIFCDK5CDK5R1KDRALDH1A1
SCHEMBL30810529 0.76 CDK5 (0.43) MIFCDK5CDK5R1KDRALDH1A1
SCHEMBL19127012 0.76 MAPK14 (0.46) MIFCDK5CDK5R1KDRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
WO-2017121444-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2017-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174241-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 ATM 419/4885MIF 4801/4885CDK5 243/4885
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 ATM 419/4885MIF 4801/4885CDK5 243/4885
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 ATM 419/4885MIF 4801/4885CDK5 243/4885
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 ATM 419/4885MIF 4801/4885CDK5 243/4885
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 ATM 419/4885MIF 4801/4885CDK5 243/4885
US-10669251-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 ATM 419/4885MIF 4801/4885CDK5 243/4885
US-11186562-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 ATM 419/4885MIF 4801/4885CDK5 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback